Drugs / anti-BCMA/CD70-CAR-T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06934447 | Apr 2025 → Apr 2028 expected | systemic lupus erythematosus | The Children's Hospital of Zhejiang University School of Medicine | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | anti-BCMA/CD70-CAR-T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06934447 ↗ |
| Modality | Cell therapy | “anti-BCMA/CD70 CAR-T cells” NCT06934447 ↗ |
| Target | CD70 | “anti-BCMA/CD70-CAR-T cells” NCT06934447 ↗ |